PMC:7299399 / 23547-23786
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T105 | 126-133 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T82 | 79-87 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T147 | 33-44 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T148 | 126-133 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T149 | 196-205 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T98 | 0-239 | Sentence | denotes | Vaccine candidates based in this application have previously been designed for SARS-CoV with high stability.72,73 Recombinant-protein vaccines and inactivated vaccines are safer but might require adjuvants to increase their immunogenicity. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 347 | 79-87 | Species | denotes | SARS-CoV | Tax:694009 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-26513244-158495 | 108-110 | 26513244 | denotes | 72 |
| 32519842-25609816-158496 | 111-113 | 25609816 | denotes | 73 |